G01N 2800/10
Musculoskeletal or connective tissue disorders
G01N2800/10 (Musculoskeletal or connective tissue disorders) appears on 852 US grants and 1,560 published applications in this corpus.
Search patents in G01N- Granted patents
- 852
- Published applications
- 1,560
- Assignees
- 844
- Inventors
- 3,181
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 1 | 0 |
| 1982 | 3 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 4 | 0 |
| 1986 | 3 | 0 |
| 1987 | 6 | 0 |
| 1988 | 3 | 0 |
| 1989 | 4 | 0 |
| 1990 | 3 | 0 |
| 1991 | 3 | 0 |
| 1992 | 2 | 0 |
| 1993 | 6 | 0 |
| 1994 | 12 | 0 |
| 1995 | 8 | 0 |
| 1996 | 11 | 0 |
| 1997 | 18 | 0 |
| 1998 | 14 | 0 |
| 1999 | 15 | 0 |
| 2000 | 21 | 0 |
| 2001 | 9 | 1 |
| 2002 | 9 | 12 |
| 2003 | 15 | 30 |
| 2004 | 11 | 27 |
| 2005 | 10 | 39 |
| 2006 | 13 | 46 |
| 2007 | 11 | 59 |
| 2008 | 8 | 57 |
| 2009 | 20 | 73 |
| 2010 | 32 | 79 |
| 2011 | 41 | 98 |
| 2012 | 29 | 85 |
| 2013 | 40 | 83 |
| 2014 | 44 | 81 |
| 2015 | 38 | 75 |
| 2016 | 34 | 98 |
| 2017 | 41 | 76 |
| 2018 | 49 | 71 |
| 2019 | 33 | 72 |
| 2020 | 46 | 76 |
| 2021 | 30 | 59 |
| 2022 | 41 | 64 |
| 2023 | 29 | 72 |
| 2024 | 30 | 46 |
| 2025 | 26 | 43 |
| 2026 | 22 | 38 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods for detection of pathogenic antiphospholipid antibodies and for identification of inhibitors29 Sep 2026US 12,748,111 B2The Scripps Research Institute
- Antibody tests for identifying Ro negative Sjogren's Syndrome and use as biomarkers for dysregulated B cell responses, B cell lymphoma, tissue fibrosis and salivary gland dysfunction15 Sep 2026US 12,736,533 B2Oklahoma Medical Research Foundation
- Method for measuring COPD biomarkers25 Aug 2026US 12,716,898 B2St. John's University
- Methods for predicting patient response to DMARDs14 Jul 2026US 12,681,015 B2Queen Mary University of London
- Methods and kits for predicting infusion reaction risk and antibody mediated loss of response by monitoring serum uric acid during pegylated uricase therapy30 Jun 2026US 12,669,498 B2Horizon Therapeutics USA, Inc.
- Electrochemical biosensors, systems, and methods of use8 Oct 2026US 2026/0309671 A1
- Novel Methods for Early Identification of Bone Healing Ability in Injured Patients1 Oct 2026US 2026/0297676 A1The Trustees of the University of Pennsylvania
- Gout diagnosis apparatus using nonlinear optics1 Oct 2026US 2026/0298907 A1Pusan National University Industry-University Cooperation Foundation
- Staining kit and method for assessing likelihood of rheumatoid arthritis disease risk using the same1 Oct 2026US 2026/0298923 A1
- System and method for assessing a risk of bone loss in a patient1 Oct 2026US 2026/0301951 A1
Most cited
By later US patents
- Methods and compositions for determining the efficacy of a treatment for ankylosing spondylitis using biomarkers148US 7,919,264 B2Abbott Biotechnology Ltd. · 2011
- Compounds and therapies for the prevention of vascular and non-vascular pathologies146US 6,117,911 ANeoRx Corporation · 2000
- Method for identifying T cells disease involved in autoimmune disease97US 5,298,396 ANational Jewish Center for Immunology and Respiratory Medicine · 1994
- Therapeutic methods and agents for diseases associated with decreased expression of AOP-1 gene or AOP-193US 7,598,228 B2Asubio Pharma Co., Ltd. · 2009
- Method and apparatus for detecting the presence of intraerythrocytic parasites80US 9,046,473 B2Abbott Point of Care Inc. · 2015